# ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) FY2026 Q2 Statement of Cash Flows

- Company: ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001787306-26-000051
- Page: https://plicit.ai/financials/arqt/fy2026-q2-cash-flow
- Chart image: https://plicit.ai/charts/arqt-fy2026-q2-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 35,070,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 12,639,000 US dollars. Net cash provided.
- **Net income (loss)**: 15,009,000 US dollars
- **Stock-based compensation expense**: 12,762,000 US dollars
- **Amortization of intangible assets**: 563,000 US dollars
- **Non-cash interest expense**: 480,000 US dollars
- **Net accretion on marketable securities**: negative 223,000 US dollars
- **Other non-cash items, net**: 277,000 US dollars
- **Accounts receivable, net**: negative 10,786,000 US dollars
- **Inventory**: negative 1,177,000 US dollars
- **Prepaid expenses and other current assets**: negative 2,546,000 US dollars
- **Accounts payable**: negative 11,536,000 US dollars
- **Accrued liabilities**: 9,955,000 US dollars
- **Operating lease liabilities**: negative 139,000 US dollars
- **Investing activities**: negative 15,224,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the investing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from maturities and sales of marketable securities), so Milestone payment for intangible asset and Proceeds from maturities and sales of marketable securities cannot be separated for this quarter. It may combine inflows and outflows.
- **Purchases of marketable securities**: negative 65,591,000 US dollars
- **Purchases of property and equipment**: negative 158,000 US dollars
- **Remaining investing cash flows, net (calculated)**: 50,525,000 US dollars
- **Financing activities**: 1,990,000 US dollars. Net cash provided.
- **Proceeds from issuance of common stock upon exercise of stock options**: 1,361,000 US dollars
- **Proceeds from issuance of common stock pursuant to employee stock purchase plan**: 1,629,000 US dollars
- **Payment of debt prepayment penalty**: negative 1,000,000 US dollars
- **Operating adjustment reconciliation**: 26,407,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 2,990,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing displayed reconciliation**: 65,749,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- **Exchange-rate effect**: negative 46,000 US dollars
- **Ending cash on Jun 30, 2026**: 34,429,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 49,699,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 641,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: 0.84×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: 12,639,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 158,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: 12,481,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income exceeds operating cash. The diagram allocates $12.64M of net income directly to operating cash and $2.37M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 12,639,000 US dollars minus 158,000 US dollars equals 12,481,000 US dollars.